Health promotion intervention among women with recent gestational diabetes mellitus: penetration, participation, and baseline findings from the Face-it randomized controlled trial.
Diabetes, Gestational
Health Promotion
Health Services Research
Public Health
Journal
BMJ open diabetes research & care
ISSN: 2052-4897
Titre abrégé: BMJ Open Diabetes Res Care
Pays: England
ID NLM: 101641391
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
received:
17
05
2023
accepted:
24
08
2023
medline:
6
10
2023
pubmed:
5
10
2023
entrez:
4
10
2023
Statut:
ppublish
Résumé
Face-it is a randomized controlled trial for women with recent gestational diabetes mellitus (GDM) and their families designed to evaluate the effect of a health promotion intervention on type 2 diabetes mellitus (T2DM) risk and quality of life. This study examined (1) the penetration and participation rates for the Face-it trial, (2) the characteristics of the participating women and the potential differences in characteristics according to partner participation status, and (3) representativity of the women at baseline. We identified women with GDM during pregnancy and invited them and their partners to a baseline examination 10-14 weeks after delivery. Representativity was assessed by comparing the baseline participants with non-participating women, the general population of women with GDM delivering in Denmark, and populations from other intervention trials. The penetration rate was 38.0% (867/2279) and the participation rate was 32.9% (285/867). The 285 women who attended baseline had a mean age of 32.7 (±4.8) years and body mass index (BMI) of 28.1 (±5.4) kg/m The penetration and participation rates were acceptable. We found a high rate of partner participation. Overall, women participating with a partner were comparable with those participating without a partner. Participating women were broadly similar to the general national GDM population, however with prepregnancy obesity, multiparity, preterm delivery, and multiple pregnancy being less represented. NCT03997773.
Identifiants
pubmed: 37793679
pii: 11/5/e003529
doi: 10.1136/bmjdrc-2023-003529
pmc: PMC10551966
pii:
doi:
Banques de données
ClinicalTrials.gov
['NCT03997773']
Types de publication
Randomized Controlled Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: KKN, IKD-P, UK, PO, CAV, ED, MT, AT, LLTA, SK, DMJ, and HTM are full time or part time employed at the Steno Diabetes Center in Copenhagen, Odense, or Aarhus. The Steno Diabetes Centers are regional public hospitals and research institutions partly funded by grants from Novo Nordisk Foundation.
Références
Clin Nutr. 2015 Aug;34(4):579-85
pubmed: 25262459
EClinicalMedicine. 2022 Aug 11;52:101614
pubmed: 35990581
J Diabetes Res. 2015;2015:798460
pubmed: 26347894
J Clin Endocrinol Metab. 2008 Dec;93(12):4774-9
pubmed: 18826999
Diabetes Res Clin Pract. 2018 Nov;145:200-213
pubmed: 29684615
J Psychiatr Res. 2015 Jun;65:166-71
pubmed: 25930074
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Obes Rev. 2022 Jan;23(1):e13359
pubmed: 34734473
Diabet Med. 2018 Jun;35(6):714-720
pubmed: 29543341
Scand J Caring Sci. 2018 Jun;32(2):756-764
pubmed: 28856697
BMC Public Health. 2021 Sep 3;21(1):1616
pubmed: 34479526
Diabetes Obes Metab. 2018 May;20(5):1246-1255
pubmed: 29360237
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Psychother Psychosom. 2015;84(3):167-76
pubmed: 25831962
BMC Public Health. 2017 Sep 4;17(1):689
pubmed: 28870192
Acta Diabetol. 2015 Jun;52(3):445-52
pubmed: 25344768
Eur J Clin Nutr. 2007 Feb;61(2):270-8
pubmed: 16929244
PLoS Med. 2016 Jul 26;13(7):e1002092
pubmed: 27459502
Int J Endocrinol. 2015;2015:423717
pubmed: 26089886
Eur J Epidemiol. 2018 Jan;33(1):27-36
pubmed: 29349587
Prev Med Rep. 2015 May 24;2:448-61
pubmed: 26844102
Am J Health Promot. 2018 Jul;32(6):1438-1446
pubmed: 29108443
Transl Behav Med. 2011 Jun;1(2):234-51
pubmed: 24073048
Implement Sci. 2015 Dec 15;10:172
pubmed: 26670418
Trials. 2020 Feb 7;21(1):146
pubmed: 32033613
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
BMC Med. 2014 Jan 24;12:12
pubmed: 24460622
Diabetes Res Clin Pract. 2011 Dec;94(3):311-21
pubmed: 22079683
Nutr J. 2013 May 24;12:68
pubmed: 23705645
Diabet Med. 2003 Jan;20(1):51-7
pubmed: 12519320
Am J Public Health. 1999 Sep;89(9):1322-7
pubmed: 10474547
Diabetes Care. 2018 Jul;41(7):1339-1342
pubmed: 29559508
J Clin Endocrinol Metab. 2021 Nov 19;106(12):e5075-e5087
pubmed: 34272865
BMJ. 2020 May 13;369:m1361
pubmed: 32404325
Obes Rev. 2018 Mar;19(3):421-429
pubmed: 29266655
JAMA Netw Open. 2022 Mar 1;5(3):e220773
pubmed: 35234881
Scand J Work Environ Health. 2015 Sep 1;41(5):486-90
pubmed: 26111225
Diabetes Care. 2007 Jul;30 Suppl 2:S242-5
pubmed: 17596479
Diabet Med. 2006 May;23(5):469-80
pubmed: 16681555
BMC Med Res Methodol. 2014 Jan 24;14:13
pubmed: 24461045
Obstet Gynecol. 2014 Sep;124(3):563-570
pubmed: 25162257
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
Front Endocrinol (Lausanne). 2018 Oct 05;9:583
pubmed: 30344509